Pharmaceutical Company Disclosures

October 19, 201012:01 AM ET

'Dollars For Docs'

SPECIAL SERIES: Dollars For Docs: How Pharma Money Influences Physician Prescriptions

Pharmaceutical sales in the United States totaled $300 billion in 2009. Below is a summary of the top pharmaceutical companies ranked by U.S. drug sales and their status for disclosing payments made to physicians and other health practitioners for marketing and promotion.

Company	2009 Sales	Disclosure Status	Notes
Pfizer	$27.8 billion	Began posting information (including payments for clinical research) in March 2010.	The company also posts information about grants for medical education, lobbying and contributions. Agreed to release the information as part of a September 2009 settlement with the U.S. Justice Department.
Merck & Co.	$19.8 billion	Began releasing information in October 2009.	The company also posts grants, political contributions and charitable contributions.
AstraZeneca	$19.8 billion	Began releasing information in August 2010.	Agreed to release the information as part of an April 2010 settlement with the U.S. Justice Department.
GlaxoSmithKline	$15 billion	Began releasing information in December 2009.	The company also posts grants and charitable contributions and plans to disclose grants for clinical trials starting in 2010.
Roche	$14.3 billion	Does not post physician payments.	Began posting grants for medical education in August.
Novartis	$13.4 billion		Agreed to release the information by March 2011 as part of a September 2010 settlement with the U.S. Justice Department.
Eli Lilly	$13.2 billion	Began releasing information in July 2009.	The company also posts grants and charitable contributions. Agreed to release the information as part of a January 2009 settlement with the U.S. Justice Department.
Johnson & Johnson	$12.8 billion	Began posting information in June 2010 by division, not centrally.	The divisions also post grants for medical education and charitable contributions. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Centocor Ortho Biotech Inc. Tibotec Therapeutics Scios Inc. Patriot Pharmaceuticals The company’s Ortho-McNeil-Janssen Pharmaceuticals division agreed to release payment information as part of an April 2010 settlement with the U.S. Department of Justice.
Amgen Corp.	$12.5 billion	Does not post physician payments.
Teva Pharmaceuticals USA	$12.1 billion		Has not responded to requests for comment.
Sanofi-Aventis	$11.1 billion	Does not post physician payments.
Abbott Laboratories	$9.5 billion	Does not post physician payments.	From a company statement: “Abbott began voluntarily disclosing grants and donations greater than $200 to U.S. medical organizations beginning with the third quarter of 2008.”
Bristol-Myers Squibb	$8.9 billion	Does not post physician payments.	From a company statement: “We also are preparing to publish information about our payments to physicians in all states as required by the Physician Payments Sunshine Act. I am unable to provide a specific date for publishing the information, but we will do so by March 1, 2012, as the law requires.” The company posts grants to independent medical education providers, patient groups, medical societies and charitable organizations on its website.
Takeda	$7.9 billion		Declined to comment on whether it would post payments.
Boehringer Ingel	$7.6 billion		Has not responded to requests for comment.